Table 2.

Tobit Regression on EQ-5D-5L Index Score.

	Excluding Recurrent VTE /Bleeding Event (n = 1695, obs = 5638)				Including Recurrent VTE /Bleeding Event (n = 1695, obs = 5365)
	Coefficient	Standard Error	P > z	95% Confidence Interval	Coefficient	Standard Error	P > z	95% Confidence Interval
Patient without active cancer
Constant	0.982	0.036	0	0.911 to 1.052	0.987	0.036	0	0.916 to 1.058
Age	−0.001	0.000	.009	−0.002 to 0.000	−0.001	0.000	.007	−0.002 to 0.000
Male	0.082	0.011	0	0.061 to 0.103	0.080	0.011	0	0.059 to 0.102
BMI	−0.003	0.001	.009	−0.005 to −0.001	−0.003	0.001	.009	−0.005 to −0.001
Previous stroke	−0.098	0.038	.011	−0.173 to −0.022	−0.099	0.039	.011	−0.175 to −0.023
Previous bleed events	−0.070	0.030	.019	−0.129 to −0.011	−0.071	0.030	.02	−0.130 to −0.011
Prolonged immobilization	−0.036	0.017	.031	−0.068 to −0.003	−0.034	0.017	.04	−0.067 to −0.002
>5 days in bed	−0.104	0.021	0	−0.145 to −0.063	−0.100	0.021	0	−0.142 to −0.059
Lower extremity paralysis	−0.227	0.052	0	−0.330 to −0.124	−0.229	0.053	0	−0.332 to −0.125
Congestive heart failure	−0.114	0.034	.001	−0.181 to −0.048	−0.109	0.035	.002	−0.176 to −0.041
Chronic respiratory disease	−0.055	0.021	.007	−0.096 to −0.015	−0.057	0.021	.006	−0.098 to −0.016
Arthritis	−0.084	0.019	0	−0.121 to −0.047	−0.083	0.019	0	−0.120 to −0.046
Bone fracture/soft-tissue trauma	−0.075	0.016	0	−0.106 to −0.043	−0.074	0.016	0	−0.106 to −0.042
Smoking history	−0.031	0.012	.009	−0.054 to −0.008	−0.033	0.012	.006	−0.057 to −0.010
Thrombophilia	0.048	0.019	.014	0.010 to 0.086	0.047	0.020	.016	0.009 to 0.086
Proximal VTE event	−0.048	0.012	0	−0.072 to −0.024	−0.048	0.012	0	−0.072 to −0.024
Recurrent VTE event during follow-up	Not included				−0.008	0.032	.811	−0.070 to 0.055
Bleeding event during follow-up	Not included				−0.013	0.027	.634	−0.065 to 0.040

Abbreviations: BMI, body mass index; Obs.: number of observations of index scores (per patient could contribute multiple, up to 5, observations); VTE, venous thromboembolism.